CG Oncology, Inc. (CGON)
74.67
+0.34
(+0.46%)
USD |
NASDAQ |
Sep 04, 16:00
74.64
-0.03
(-0.04%)
After-Hours: 20:00
CG Oncology 1 Year Total Returns (Daily) : 141.3% for Sept. 4, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 04, 2026 | 141.3% |
| September 03, 2026 | 159.3% |
| September 02, 2026 | 171.6% |
| September 01, 2026 | 182.8% |
| August 31, 2026 | 180.2% |
| August 28, 2026 | 178.3% |
| August 27, 2026 | 198.4% |
| August 26, 2026 | 190.1% |
| August 25, 2026 | 210.6% |
| August 24, 2026 | 190.7% |
| August 21, 2026 | 207.2% |
| August 20, 2026 | 204.0% |
| August 19, 2026 | 215.6% |
| August 18, 2026 | 192.0% |
| August 17, 2026 | 200.0% |
| August 14, 2026 | 189.0% |
| August 13, 2026 | 182.0% |
| August 12, 2026 | 208.6% |
| August 11, 2026 | 221.7% |
| August 10, 2026 | 208.1% |
| August 07, 2026 | 208.4% |
| August 06, 2026 | 196.0% |
| August 05, 2026 | 168.8% |
| August 04, 2026 | 173.7% |
| August 03, 2026 | 162.8% |
| Date | Value |
|---|---|
| July 31, 2026 | 166.7% |
| July 30, 2026 | 171.4% |
| July 29, 2026 | 165.4% |
| July 28, 2026 | 180.8% |
| July 27, 2026 | 181.7% |
| July 24, 2026 | 165.2% |
| July 23, 2026 | 170.2% |
| July 22, 2026 | 166.5% |
| July 21, 2026 | 166.6% |
| July 20, 2026 | 162.4% |
| July 17, 2026 | 152.5% |
| July 16, 2026 | 166.5% |
| July 15, 2026 | 192.6% |
| July 14, 2026 | 177.1% |
| July 13, 2026 | 171.3% |
| July 10, 2026 | 177.5% |
| July 09, 2026 | 171.2% |
| July 08, 2026 | 168.9% |
| July 07, 2026 | 163.6% |
| July 06, 2026 | 157.5% |
| July 02, 2026 | 163.7% |
| July 01, 2026 | 169.0% |
| June 30, 2026 | 173.3% |
| June 29, 2026 | 184.1% |
| June 26, 2026 | 176.0% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Tyra Biosciences, Inc. | 136.0% |
| Arrowhead Pharmaceuticals, Inc. | 208.4% |
| Oncolytics Biotech, Inc. | -21.93% |
| Sangamo Therapeutics, Inc. | -69.63% |
| Sarepta Therapeutics, Inc. | 21.89% |